Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    15569934 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Nivolumab;   Drug: Ipilimumab
2 Recruiting Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Condition: Neoplasms
Intervention: Genetic: Blood and tumor samples

Study has passed its completion date and status has not been verified in more than two years.